Beyond Lifelong Medication: Modern Interventions for BPH

A weak stream, urgency and frequent night-time trips do not always have the same cause. Before recommending surgery, your urologist may assess urine flow, residual urine, prostate size and anatomy, infection and kidney function. Selected patients need additional bladder testing.

Alpha-blockers relax muscle around the outlet. Other medicines can reduce prostate growth over time. If a treatment has not helped, discuss whether it has had enough time, whether side effects are limiting it and whether a different mechanism is needed. Do not stop prescribed treatment without an agreed plan.

A procedure may be appropriate when symptoms remain bothersome despite suitable treatment, medicines are not tolerated, or complications develop. Recurrent retention, recurrent infections, bladder stones or effects on the upper urinary tract can make the discussion more pressing.

The consultation should distinguish relief of obstruction from treatment of an overactive or weakened bladder. Some urgency or night-time urination can persist after technically successful outlet surgery. Understanding this beforehand helps set realistic goals.

Transurethral resection of the prostate uses a telescope through the urethra to remove obstructing tissue. There is no external skin incision. A catheter is usually needed initially, and blood in the urine and temporary urinary irritation are part of the recovery discussion.

TURP is an established option, but bleeding, infection, scar-related narrowing and changes in ejaculation are important considerations. It treats benign obstruction rather than removing the entire prostate as in radical prostatectomy for cancer. Ask what result is realistic for your prostate size and bladder function.

Holmium laser enucleation of the prostate uses a laser to separate the enlarged inner tissue from the surrounding capsule. The tissue is moved into the bladder, broken into smaller pieces and removed. It can be useful across a broad range of prostate sizes, including larger glands.

HoLEP can provide substantial relief of obstruction, but temporary leakage and urinary irritation can occur. Dry or backward ejaculation is common after tissue-removing procedures. An erection and ejaculation are different functions; a change in one does not automatically mean loss of the other. Fertility plans should be discussed before treatment.

For selected anatomy and priorities, alternatives may include implants that hold prostate tissue away from the urethra or water-vapour treatment that reduces tissue over time. These may appeal to some patients who place a high value on preserving ejaculation. They are not suitable for every gland and do not guarantee preservation.

Relief may be less immediate with some approaches, and the likelihood of needing additional treatment is part of the choice. Prostate artery embolisation is another option in selected settings and involves an interventional radiologist. Ask what is available locally and why a particular approach is being offered; this guide does not confirm that every option is available at the practice.

A useful comparison puts your goals beside the practical consequences of each option. “Laser” or “minimally invasive” describes a tool or approach, not a guarantee of the best outcome. Ask for the treating team’s explanation of expected benefit, relevant experience and follow-up.

Make arrangements for catheter care, time away from strenuous activity and a review date. Blood-thinning medicines require a specific plan with the clinicians who prescribe them. Do not stop them independently.

Before discharge, ask which symptoms are expected and which should trigger a call. Follow the individual instructions for activity, fluids and medicines. Keep the review even if your stream improves quickly: recovery includes checking how the bladder is emptying and discussing any persistent symptoms.